Menu

Events & News

Upcoming events

RPA 2025 Annual Meeting
Apr 3-6
Conference
RPA 2025 Annual Meeting
ANNA National Symposium
May 1-4
Conference
ANNA National Symposium
NTI 2025 New Orleans
May 18-21
Conference
NTI 2025 New Orleans
NBLU 2025
Aug 12-16
Conference
NBLU 2025
RETHINK Conference
Aug 18-20
Conference
RETHINK Conference
AHCA/NCAL Annual Convention
Oct 12-15
Conference
AHCA/NCAL Annual Convention
Becker’s 13th Annual CEO + CFO Roundtable
Nov 3-6
Webinar
Becker’s 13th Annual CEO + CFO Roundtable
ASN Kidney Week 2025
Nov 5-9
Conference
ASN Kidney Week

Catch up on past events

Press highlights

"[Auxiliary care] is growing in demand as acuity is rising in facilities, patients tend to be less stable, and hospitals are trying to minimize lengths of stay."

"The home dialysis developer’s CEO discusses leadership, leaping before you look and making medtech for the home and hospital."

"Nearly 200 comments supportive of Tablo as a significant innovative improvement over the existing technology were submitted."

"But the winners and honorable mentions span a gamut of issues related to medical challenges, including a new device that makes dialysis less of a burden."

Nephrology Times
Innovative Solutions in Nephrology: Navigating the Shift From Peritoneal to Home Hemodialysis
As nephrology continues to advance, so must the methods for managing dialysis patients. One area ripe for innovation is the transition from peritoneal dialysis (PD) to home hemodialysis (HHD).
MedCity News
Home Dialysis Advances Will Make Transplant Wait a Little Easier
Right now, approximately 92,000 Americans are waiting for a kidney transplant. One good way to reduce their suffering immediately is to make dialysis a better experience while they wait. Let’s help them bring it home.
home care patient using Tablo machine
McKnight’s Home Care
Home hemodialysis a better option for patients with cardiovascular concerns, study finds
In the private sector, partnerships have helped fuel home dialysis participation. Recently, US Renal Care partnered with medical technology Outset Medical to offer patients accessible and easy-to-use home dialysis tools.
1 2 3 … 15 16 17
See all press highlights
1883-v1 (v1.0)
Back To Top

INDICATIONS FOR USE:

The Tablo® Hemodialysis System and TabloCart™ is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription and observed by a trained individual who is considered competent in the use of the device. The Tablo Hemodialysis System is also indicated for use in the home. Treatment types available include Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/ SLEDD), Prolonged Intermittent Renal Replacement Therapy (PIRRT), and Isolated Ultrafiltration.

This device is not indicated for continuous renal replacement therapy (CRRT) and is cleared for use for up to 24 hours. The dialysate generated by this device is not sterile and should not be used for intravenous (IV) infusion.
2214-v2
Tablo

Clinical evidence

EMR Connect

Services

 

Patients

Kidney health 101

Request more info

Why home dialysis

 

Healthcare providers

Administrators

Nurses

Nephrologists

Request a demo

Skilled Nursing Facilities

Resources

Blog

Customer resources

Events & news

FAQ

Press highlights

 

 

About

Careers

Contact

Investors

 

Stay connected
Stay connected
© 2024 Outset Medical, Inc. All rights reserved. Outset, Tablo, TabloCart, MyTablo, TabloHub, and Better Begins Now are trademarks of our company.

Consumer Health Data Privacy

Cookie policy

Do not sell/share my personal info

Important Safety Information

Patents

Privacy policy

Terms of Use